|
US2002076378A1
|
|
Polymers
|
|
AU2002226818A1
|
|
Ultrasonic imaging of perfusion using gases with different partial pressures
|
|
AU9245601A
|
|
Peptide-based compounds
|
|
GB0122049D0
|
|
Method
|
|
AU7468301A
|
|
Contrast agents
|
|
GB0111279D0
|
|
Radiolabelled liposomes
|
|
AU5068301A
|
|
Peptide-based compounds
|
|
WO0174245A1
|
|
Method of magnetic resonance imaging
|
|
US2001019710A1
|
|
Contrast agents
|
|
GB0025070D0
|
|
Contrast agents
|
|
GB0022341D0
|
|
Method
|
|
US6406680B1
|
|
X-ray contrast agents
|
|
AU6004100A
|
|
Process for the deprotection of protected thiols
|
|
WO0074593A1
|
|
Ventilation system
|
|
GB0013352D0
|
|
Improvements in or relating to diagnostic imaging
|
|
AU4598600A
|
|
Methods of magnetic resonance imaging (mri) using contract agent solutions formed from the dissolution of hyperpolarised materials
|
|
WO0072031A1
|
|
Methods of magnetic resonance imaging (mri) using contract agent solutions formed from the dissolution of hyperpolarised materials
|
|
AU4588100A
|
|
Contrast media
|
|
GB0009353D0
|
|
Method
|
|
GB0009042D0
|
|
Contrast agents
|
